- Home
- IVT vs ZLAB Comparison
IVT vs ZLAB Comparison
Compare IVT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVT | ZLAB |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2005 | 2017 |
Fundamental Metrics
Financial Performance| Metric | IVT | ZLAB |
|---|---|---|
| Price | $32.63 | $26.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $32.50 | ★ $49.60 |
| AVG Volume (30 Days) | 521.7K | ★ 1.3M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ 647.37 | 38.46 |
| EPS | ★ 0.08 | N/A |
| Revenue | $299,169,000.00 | ★ $460,156,000.00 |
| Revenue This Year | $8.42 | $9.75 |
| Revenue Next Year | $5.25 | $26.03 |
| P/E Ratio | $408.50 | ★ N/A |
| Revenue Growth | 9.20 | ★ 15.33 |
| 52 Week Low | $26.81 | $15.96 |
| 52 Week High | $37.22 | $34.72 |
Technical Indicators
Market Signals| Indicator | IVT | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 37.84 | 67.47 |
| Support Level | $32.38 | $16.84 |
| Resistance Level | $33.19 | $27.08 |
| Average True Range (ATR) | 0.50 | 0.87 |
| MACD | 0.04 | -0.13 |
| Stochastic Oscillator | 31.58 | 84.97 |
Price Performance
Historical ComparisonAbout IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.